Moderna, Inc. (NASDAQ:MRNA – Get Rating)’s share price dropped 6% on Monday after an insider sold shares in the company. The company traded as low as $166.66 and last traded at $166.76. Approximately 74,353 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 6,020,542 shares. The stock had previously closed at $177.35.Specifically, insider Juan Andres sold 4,000 shares of the business’s stock in a transaction on Friday, October 28th. The shares were sold at an average price of $150.00, for a total value of $600,000.00. Following the completion of the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,734,900. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, insider Juan Andres sold 4,000 shares of the business’s stock in a transaction on Friday, October 28th. The shares were sold at an average price of $150.00, for a total value of $600,000.00. Following the completion of the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,734,900. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, President Stephen Hoge sold 1,085 shares of the business’s stock in a transaction on Tuesday, November 29th. The shares were sold at an average price of $173.80, for a total transaction of $188,573.00. Following the completion of the sale, the president now directly owns 1,627,416 shares of the company’s stock, valued at $282,844,900.80. The disclosure for this sale can be found here. Insiders sold a total of 541,899 shares of company stock valued at $77,505,786 over the last ninety days. Insiders own 17.30% of the company’s stock.